Deprecated: Creation of dynamic property WhitelabelOptions::$_title is deprecated in /home/grassnews/public_html/wp-content/themes/zox-news/admin/admin-page.php on line 79
MSCI Equity Indexes May 2019 Index Review – GrassNews
Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

MSCI Equity Indexes May 2019 Index Review

Published

on

Reading Time: 9 minutes

LONDON–(BUSINESS WIRE)–MSCI Inc. (NYSE:MSCI), a leading provider of research-based indexes and
analytics, announced the results of the May 2019 Semi-Annual Index
Review for the MSCI Equity Indexes – including the MSCI Global Standard,
MSCI Global Small Cap and MSCI Micro Cap Indexes, the MSCI Global Value
and Growth Indexes, the MSCI Frontier Markets, and MSCI Frontier Markets
Small Cap Indexes, the MSCI Global Islamic and MSCI Global Islamic Small
Cap Indexes, the MSCI Pan-Euro and MSCI Euro Indexes, the MSCI US Equity
Indexes, the MSCI US REIT Index, the MSCI China A Indexes, MSCI China A
Onshore Indexes and the MSCI China All Shares Indexes. All changes will
be implemented as of the close of May 28, 2019. These changes have been
posted on the Index Review web page on MSCI’s web site at https://www.msci.com/index-review.

Inclusion of the MSCI Saudi Arabia Indexes in Emerging Markets:
Coinciding with this Index Review, MSCI will implement the first step of
the inclusion of the MSCI Saudi Arabia Indexes in the MSCI Emerging
Markets Indexes. Thirty Saudi Arabian securities will be added at half
of their FIF1-adjusted market capitalization, representing an
aggregate weight of 1.42% in the MSCI Emerging Markets Index. The second
and final step of the inclusion will coincide with the August 2019
Quarterly Index Review.

Inclusion of the MSCI Argentina Indexes in Emerging Markets: MSCI
will reclassify the MSCI Argentina Indexes from Frontier Markets to
Emerging Markets in one step coinciding with this Index Review. Eight
Argentinian securities will be added at an aggregate weight of 0.26% in
the MSCI Emerging Markets Index.

Weight Increase of China A Shares in Emerging Markets: MSCI will
implement the first step of the weight increase of China A shares in the
MSCI Emerging Markets Indexes. Twenty-six China A shares (18 of which
are ChiNext stocks) will be added to the MSCI China Index and the
inclusion factor for 238 existing constituents will be increased from
0.05 to 0.10. China A shares will have an aggregate weight of 5.25% and
1.76% in the MSCI China and MSCI Emerging Markets Indexes, respectively.

Advertisement
Stake.com

As a reminder, the weight increase of China A shares in the MSCI
Emerging Markets Indexes will be implemented through a three-step
process. The FIF-adjusted market capitalization of China A shares will
be further increased to 0.15 as part of the August 2019 Quarterly Index
Review and then to 0.20, together with the inclusion of Mid Cap China A
shares, in the final step as part of the November 2019 Semi-Annual Index
Review.

MSCI has published the list of constituents of the MSCI Saudi Arabia,
MSCI Argentina and MSCI China A Indexes to reflect the results of the
May 2019 Semi-Annual Index Review at https://www.msci.com/market-classification.

In addition, MSCI has updated the list of China A Mid Cap securities
that may potentially be added to the MSCI China and the MSCI Emerging
Markets Indexes as part of the third step of the weight increase to be
implemented at the November 2019 Semi-Annual Index Review.

MSCI Global Standard Indexes: One hundred twenty-two securities
will be added to and 41 securities will be deleted from the MSCI ACWI
Index. In the MSCI World Index, the three largest additions measured by
full company market capitalization will be Knorr-Bremse (Germany), Snap
A (USA) and Twilio A (USA). The three largest additions to the MSCI
Emerging Markets Index measured by full company market capitalization
will be Saudi Basic Industries Corporation (Saudi Arabia), Saudi Telecom
Company (Saudi Arabia) and Al Rajhi Banking and Investment Corporation
(Saudi Arabia).

MSCI Global Small Cap Indexes: There will be 344 additions to and
195 deletions from the MSCI ACWI Small Cap Index.

Advertisement
Stake.com

MSCI Global Investable Market Indexes: There will be 400
additions to and 170 deletions from the MSCI ACWI Investable Market
Index (IMI).

MSCI Global All Cap Indexes: There will be 350 additions to and
148 deletions from the MSCI World All Cap Index.

MSCI Frontier Markets Indexes: There will be two additions to and
23 deletions from the MSCI Frontier Markets Index. The two additions to
the MSCI Frontier Markets Index will be Petrovietnam Power (Vietnam) and
Banque De Tunisie (Tunisia). There will be 12 additions to and 24
deletions from the MSCI Frontier Markets Small Cap Index.

MSCI will launch the MSCI Malta Investable Market Index as a Standalone
Index as part of the May 2019 Semi-Annual Index Review. The index will
initially include one Standard Size-Segment constituent and two Small
Cap Size-Segment constituents.

MSCI Global Islamic Indexes: Seventy-one securities will be added
to and 49 securities will be deleted from the MSCI ACWI Islamic Index.
The three largest additions to the MSCI ACWI Islamic Index measured by
full company market capitalization will be Abbott Laboratories (USA),
Saudi Basic Industries Corporation (Saudi Arabia) and Linde (New) (USA).
There will be no additions to and two deletions from the MSCI Gulf
Cooperation Council (GCC) Countries ex Saudi Arabia IMI Islamic Index.

Advertisement
Stake.com

MSCI US Equity Indexes: There will be seven securities added to
and four securities deleted from the MSCI US Large Cap 300 Index. The
three largest additions to the MSCI US Large Cap 300 Index measured by
full company market capitalization will be Xilinx, Arista Networks and
Transdigm Group Inc.

Thirty-one securities will be added to and 20 securities will be deleted
from the MSCI US Mid Cap 450 Index. The three largest additions to the
MSCI US Mid Cap 450 Index measured by full company market capitalization
will be Omnicom Group, Altice USA A and Apache Corporation.

One hundred fifty securities will be added to and 62 securities will be
deleted from the MSCI US Small Cap 1750 Index. The three largest
additions to the MSCI US Small Cap 1750 Index measured by full company
market capitalization will be Smartsheet A, ADT and Avnet.

There will be 49 additions to and 30 deletions from the MSCI US Micro
Cap Index.

For the MSCI US Investable Market Value Index, there will be 149
additions or upward changes in Value Inclusion Factor (VIFs), and 126
deletions or downward changes in VIFs. For the MSCI US Investable Market
Growth Index, there will be 196 additions or upward changes in Growth
Inclusion Factors (GIFs), and 128 deletions or downward changes in GIFs.

Advertisement
Stake.com

MSCI US REIT Index: There will be one addition to and two
deletions from the MSCI US REIT Index. The addition to the MSCI US REIT
Index will be Innovative Industrial Properties, Inc.

MSCI China A Indexes: There will be 26 additions to and no
deletions from the MSCI China A Large Cap Index resulting in 264 index
constituents. There will be 29 additions to and five deletions from the
MSCI China A Mid Cap Index resulting in 173 index constituents.

MSCI China A Onshore Indexes: There will be 109 additions to and
three deletions from the MSCI China A Onshore Index. The three largest
additions to the MSCI China A Onshore Index will be Wens Foodstuff Group
A, Contemporary A and Shenzhen Mindray A. There will be 503 additions to
and 49 deletions from the MSCI China A Onshore Small Cap Index. Most of
the additions are newly eligible ChiNext stocks.

MSCI China All Shares Indexes: There will be 66 additions to and
10 deletions from the MSCI China All Shares Index. The three largest
additions to the MSCI China All Shares Index will be Wens Foodstuff
Group A, Contemporary A and Shenzhen Mindray A. There will be 522
additions to and 46 deletions from the MSCI China All Shares Small Cap
Index. Most of the additions are newly eligible ChiNext stocks.

-Ends-

Advertisement
Stake.com

About MSCI

MSCI is a leading provider of critical decision support tools and
services for the global investment community. With over 45 years of
expertise in research, data and technology, we power better investment
decisions by enabling clients to understand and analyze key drivers of
risk and return and confidently build more effective portfolios. We
create industry-leading research-enhanced solutions that clients use to
gain insight into and improve transparency across the investment
process. To learn more, please visit www.msci.com.

This document and all of the information contained in it, including
without limitation all text, data, graphs, charts (collectively, the
“Information”) is the property of MSCI Inc. or its subsidiaries
(collectively, “MSCI”), or MSCI’s licensors, direct or indirect
suppliers or any third party involved in making or compiling any
Information (collectively, with MSCI, the “Information Providers”) and
is provided for informational purposes only. The Information may not be
modified, reverse-engineered, reproduced or redisseminated in whole or
in part without prior written permission from MSCI.

The Information may not be used to create derivative works or to verify
or correct other data or information. For example (but without
limitation), the Information may not be used to create indexes,
databases, risk models, analytics, software, or in connection with the
issuing, offering, sponsoring, managing or marketing of any securities,
portfolios, financial products or other investment vehicles utilizing or
based on, linked to, tracking or otherwise derived from the Information
or any other MSCI data, information, products or services.

The user of the Information assumes the entire risk of any use it may
make or permit to be made of the Information. NONE OF THE INFORMATION
PROVIDERS MAKES ANY EXPRESS OR IMPLIED WARRANTIES OR REPRESENTATIONS
WITH RESPECT TO THE INFORMATION (OR THE RESULTS TO BE OBTAINED BY THE
USE THEREOF), AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW,
EACH INFORMATION PROVIDER EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES
(INCLUDING, WITHOUT LIMITATION, ANY IMPLIED WARRANTIES OF ORIGINALITY,
ACCURACY, TIMELINESS, NON-INFRINGEMENT, COMPLETENESS, MERCHANTABILITY
AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO ANY OF THE
INFORMATION.

Advertisement
Stake.com

Without limiting any of the foregoing and to the maximum extent
permitted by applicable law, in no event shall any Information Provider
have any liability regarding any of the Information for any direct,
indirect, special, punitive, consequential (including lost profits) or
any other damages even if notified of the possibility of such damages.
The foregoing shall not exclude or limit any liability that may not by
applicable law be excluded or limited, including without limitation (as
applicable), any liability for death or personal injury to the extent
that such injury results from the negligence or willful default of
itself, its servants, agents or sub-contractors.

Information containing any historical information, data or analysis
should not be taken as an indication or guarantee of any future
performance, analysis, forecast or prediction. Past performance does not
guarantee future results.

The Information should not be relied on and is not a substitute for the
skill, judgment and experience of the user, its management, employees,
advisors and/or clients when making investment and other business
decisions. All Information is impersonal and not tailored to the needs
of any person, entity or group of persons.

None of the Information constitutes an offer to sell (or a solicitation
of an offer to buy), any security, financial product or other investment
vehicle or any trading strategy.

It is not possible to invest directly in an index. Exposure to an asset
class or trading strategy or other category represented by an index is
only available through third party investable instruments (if any) based
on that index. MSCI does not issue, sponsor, endorse, market, offer,
review or otherwise express any opinion regarding any fund, ETF,
derivative or other security, investment, financial product or trading
strategy that is based on, linked to or seeks to provide an investment
return related to the performance of any MSCI index (collectively,
“Index Linked Investments”). MSCI makes no assurance that any Index
Linked Investments will accurately track index performance or provide
positive investment returns. MSCI Inc. is not an investment adviser or
fiduciary and MSCI makes no representation regarding the advisability of
investing in any Index Linked Investments.

Advertisement
Stake.com

Index returns do not represent the results of actual trading of
investible assets/securities. MSCI maintains and calculates indexes, but
does not manage actual assets. Index returns do not reflect payment of
any sales charges or fees an investor may pay to purchase the securities
underlying the index or Index Linked Investments. The imposition of
these fees and charges would cause the performance of an Index Linked
Investment to be different than the MSCI index performance.

The Information may contain back tested data. Back-tested performance is
not actual performance, but is hypothetical. There are frequently
material differences between back tested performance results and actual
results subsequently achieved by any investment strategy.

Constituents of MSCI equity indexes are listed companies, which are
included in or excluded from the indexes according to the application of
the relevant index methodologies. Accordingly, constituents in MSCI
equity indexes may include MSCI Inc., clients of MSCI or suppliers to
MSCI. Inclusion of a security within an MSCI index is not a
recommendation by MSCI to buy, sell, or hold such security, nor is it
considered to be investment advice.

Data and information produced by various affiliates of MSCI Inc.,
including MSCI ESG Research LLC and Barra LLC, may be used in
calculating certain MSCI indexes. More information can be found in the
relevant index methodologies on www.msci.com.

MSCI receives compensation in connection with licensing its indexes to
third parties. MSCI Inc.’s revenue includes fees based on assets in
Index Linked Investments. Information can be found in MSCI Inc.’s
company filings on the Investor Relations section of www.msci.com.

Advertisement
Stake.com

MSCI ESG Research LLC is a Registered Investment Adviser under the
Investment Advisers Act of 1940 and a subsidiary of MSCI Inc. Except
with respect to any applicable products or services from MSCI ESG
Research, neither MSCI nor any of its products or services recommends,
endorses, approves or otherwise expresses any opinion regarding any
issuer, securities, financial products or instruments or trading
strategies and MSCI’s products or services are not intended to
constitute investment advice or a recommendation to make (or refrain
from making) any kind of investment decision and may not be relied on as
such. Issuers mentioned or included in any MSCI ESG Research materials
may include MSCI Inc., clients of MSCI or suppliers to MSCI, and may
also purchase research or other products or services from MSCI ESG
Research. MSCI ESG Research materials, including materials utilized in
any MSCI ESG Indexes or other products, have not been submitted to, nor
received approval from, the United States Securities and Exchange
Commission or any other regulatory body.

Any use of or access to products, services or information of MSCI
requires a license from MSCI. MSCI, Barra, RiskMetrics, IPD and other
MSCI brands and product names are the trademarks, service marks, or
registered trademarks of MSCI or its subsidiaries in the United States
and other jurisdictions. The Global Industry Classification Standard
(GICS) was developed by and is the exclusive property of MSCI and
Standard & Poor’s. “Global Industry Classification Standard (GICS)” is a
service mark of MSCI and Standard & Poor’s.

MIFID2/MIFIR notice: MSCI ESG Research LLC does not distribute or act as
an intermediary for financial instruments or structured deposits, nor
does it deal on its own account, provide execution services for others
or manage client accounts. No MSCI ESG Research product or service
supports, promotes or is intended to support or promote any such
activity. MSCI ESG Research is an independent provider of ESG data,
reports and ratings based on published methodologies and available to
clients on a subscription basis. We do not provide custom or one-off
ratings or recommendations of securities or other financial instruments
upon request.

Privacy notice: For information about how MSCI ESG Research LLC collects
and uses personal data concerning officers and directors, please refer
to our Privacy Notice at https://www.msci.com/privacy-pledge.

1 Foreign Inclusion Factor

Advertisement
Stake.com

Contacts

Media Inquiries
PR@msci.com
Sam
Wang +1 212 804 5244
Melanie Blanco +1 212 981 1049
Laura
Hudson +44 20 7336 9653

MSCI Global Client Service
EMEA
Client Service + 44 20 7618.2222
Americas Client Service +1 888 588
4567 (toll free)
Asia Pacific Client Service + 852 2844 9333

Advertisement
Stake.com

Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis

Published

on

im-cannabis-shares-commence-trading-on-6:1-consolidated-basis

TORONTO and GLIL YAM, Israel, July 12, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IM Cannabis“), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that, further to its press release dated July 5, 2024, effective today the Company’s common shares (“Common Shares“) are trading on the Canadian Securities Exchange (the “CSE“) and Nasdaq Stock Market LLC (“NASDAQ“) on a 6:1 post-consolidated basis (the “Consolidation“).

The Company’s trading symbol remains “IMCC” on both the CSE and NASDAQ. The Company’s new CUSIP and ISIN numbers are 44969Q406 and CA44969Q4060, respectively.

After giving effect to the Consolidation, the Common Shares were reduced from 13,394,136 to 2,232,357 Common Shares. No fractional Common Shares were issued in connection with the Consolidation. Instead, all fractional Common Shares equal to or greater than one-half resulting from the Consolidation were rounded to the next whole number, otherwise, the fractional Common Share were cancelled. The exercise price and/or conversion price and number of Common Shares issuable under any of the Company’s outstanding convertible securities were proportionately adjusted in connection with the Consolidation.

Computershare Investor Services Inc., the Company’s registrar and transfer agent for the Common Shares, has mailed letters of transmittal to registered shareholders of record as of July 12, 2024 providing instructions for the exchange of their Common Shares as soon as practicable following the effective date. Registered shareholders may also obtain a copy of the letter of transmittal by accessing the Company’s SEDAR+ profile at www.sedarplus.ca. Until surrendered, each Common Share certificate or direct registration system statement representing pre-consolidated Common Shares will represent the number of whole post-consolidated Common Shares to which the holder is entitled as a result of the Consolidation. No action is required by beneficial holders to receive post-consolidation Common Shares in connection with the Consolidation. Beneficial holders who hold their Common Shares through intermediaries (e.g., a broker, bank, trust company investment dealer or other financial institution) and who have questions regarding how the Consolidation will be processed should contact their intermediaries with respect to the Consolidation.

About IM Cannabis Corp. 

Advertisement
Stake.com

IM Cannabis (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IM Cannabis’ products throughout the entire value chain. In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements“). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to the Company amplifying its commercial and brand power to become a global high-quality cannabis player.

Forward-looking information is based on assumptions that may prove to be incorrect, including but not limited to: the Company’s ability to maintain the listing requirements of the CSE and NASDAQ; the Company’s ability to focus on Israel, Germany and Europe; the Company’s ability to realize upon the stated benefits of the partial legalization of cannabis in Germany; and the Company amplifying its commercial and brand power to become a global high-quality cannabis player. The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks. These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company’s ability to continue to meet the listing requirements of the CSE and NASDAQ; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical Herbs Ltd. (collectively, the “Group“) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East; the risk of the Company’s inability to capitalize upon the partial legalization of cannabis in Germany; and risks the Company will be unable to amplify its commercial and brand power and/or be unable to become a global high-quality cannabis player.

Advertisement
Stake.com

Please see the other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual report dated March 28, 2024, which is available on the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov/edgar. Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
+972-77-3603504
info@imcannabis.com

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Advertisement
Stake.com

Cision View original content:https://www.prnewswire.co.uk/news-releases/im-cannabis-shares-commence-trading-on-61-consolidated-basis-302194981.html

Continue Reading

Cannabis

Legal Cannabis Market Share Value Projected to Reach USD 194.5 Billion, at 16.9% CAGR by 2034: Prophecy Market Insights

Published

on

Covina, July 11, 2024 (GLOBE NEWSWIRE) — The study concludes that the global legal cannabis market size and share is expected to grow at a CAGR of 16.9% between 2024 and 2034. The market revenue of USD 47 Billion in 2024 is expected to grow up to USD 194.5 Billion by 2034.

Cannabis was an illicit drug before, but its legalization process is on fast track today in many nations around the globe, opening a multibillion-dollar market with huge growth potential. The said market is bifurcated into two categories: medical cannabis, used for the treatment of various diseases, and recreational cannabis, for fun and other purposes. Most marijuana consumers are young, especially millennials. Males use it more than females, while the level of consumption is also predicated by class and thereby affects the rate of consumption. Psychographics show that marijuana consumers are social, open to experiences, and concerned about health; the last two probably represent a broader moving trend to natural products and alternate medicine.

The legal cannabis market offers a huge amount of variety, starting from flowers to extracts and consumables like cookies and chocolate that can be applied topically on the skin. Concentrations are gaining their following and popularity because of their potency. Also very popular are the edibles—baked goods, particularly cookies, and sweets—that appeal to those who crave discreetness and effectiveness all at once in consumption.

Download a Free Sample Research Report with Latest Industry Insights: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5434      

Our Free Sample Report includes:

Advertisement
Stake.com
  • Overview & introduction of market study
  • Revenue and CAGR of the market 
  • Drivers & Restrains factors of the market 
  • Major key players in the market 
  • Regional analysis of the market with a detailed graph
  • Detailed segmentation in tabular form of market 
  • Recent developments/news of the market 
  • Opportunities & Challenges of the Market

Some of the Key Market Players:

  • Aurora Cannabis
  • Cresco Labs
  • Jazz Pharmaceuticals
  • Verano Holdings
  • Canopy Growth Corporation
  • Green Thumb Industries
  • Trulieve Cannabis
  • MedMen
  • Aphria
  • Cronos Group
  • Curaleaf
  • GW Pharmaceuticals, plc.
  • The Green Organic Dutchman

To Know More on Market Players, Download a Free Sample Report Here: https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/5434    

Analyst View:

Global cannabis regulations differ, but most countries are legalizing it fast, thereby creating a multibillion-dollar market with huge growth potential. The market segments include cannabis for recreation and cannabis for medical use. Young people form a huge part of the cannabis users, particularly the millennial group who exhibit a social class influence. Due to early legalization and permissive rules, North America is the leader of the legal cannabis business concerning product variety. The constantly changing process of the market keeps including new and different consumers and substances like CBD or substances for euphoric-balming effects.

Legal Cannabis Market: Report Scope
Report Attributes Details
Market value in 2024 USD 47 Billion 
Market value in 2034 USD 194.5 Billion
CAGR 16.9% from 2024 – 2034
Base year 2023
Historical data 2019-2022
Forecast period 2024-2034

Market Dynamics:

Drivers:

Advertisement
Stake.com

Growing Recognition and Legalization

  • Together, the increasing number of countries legalizing cannabis and the health benefits derived from medical marijuana easily make the global legal cannabis market ripe for significant growth. North America dominates the market due to major contributors such as the US, Canada, the UK, Germany, and Australia. The medicinal properties of cannabis will most probably drive massive growth in the medical cannabis market. Recreational use of marijuana is projected to have the fastest growth rate, and, as such, create jobs and boost the economy. The growth of the market results from geographical expansion, regulatory frameworks, and technological enhancements.

Increasing Customer Requirements

  • It’s the change in consumer expectations that’s driving big shifts in the legal cannabis sector. Companies are rolling out new product lines to cater to health-conscious consumers who demand a wider variety of cannabis-infused products. Where consumers want organically grown and pesticide-free cannabis, quality, and safety also rank very high. Consumers demand personalized experiences, where buyers and dispensaries are very important in guiding clientele to the right products. Moreover, there is an increase in sustainability and social responsibility due to customers valuing companies advocating for them. Technological integration is also being utilized to enhance convenience and engagement measures.

Request for a Discounted Price on this Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-discount/5434       

Market Trends:

Benefits of Medicine and Research

  • Growth opportunities in legal cannabis mainly come from the legalization of their consumption, primarily for medical use. There are several medical diseases where the benefits of the use of cannabis have been proved, and the FDA has approved quite a few drugs derived from this plant. Improved cultivation, extraction, and testing technologies are also able to raise the quality and safety of products. The medicinal properties of cannabis are also opening up new options in treatment today, especially with those disorders resistant to traditional medications. Growing awareness of the potential economic opportunities that cannabis avails itself to could further drive the development of new innovative products and treatments, thereby accelerating market growth.

Segmentation:

Legal Cannabis Market is segmented based on Source, Compound, Products, and Region.

Source Insights

Advertisement
Stake.com
  • From the flowers, which have classically been the traditional form of cannabis for as long as anyone can remember, to a large collection of strains with different cannabinoid levels, the flower truly captures the capabilities of the plant. Seed oil is another source that is not psychoactive in nature but is popular mainly due to its abundance of vital fatty acids and possible health benefits. Other sources are concentrated and super-potent cannabis products like trichomes, kief, and live resin. The infused product market is bound to grow with rising demand for seed oil. All in all, cannabis continues changing to best accommodate these different types of customers.

Compound Insights

  • Tetrahydrocannabinol is the widest cannabinoid used and has euphoric-balming effects. With increasing education among consumers, it can maintain its market share. One of the non-psychotic components is CBD, which helps in pain management and sleep quality, amongst others. Balanced THC & CBD: This segment caters to customers looking for a balanced experience by balancing the analgesic, relaxing properties of THC with the anxiety-reducing, focused properties of CBD.

Product Insights

  • Cannabis oil is quite often a concentrate, one can administer it topically for pain, consume it right out of the container, or use it in edibles. Cannabis drinks, like coffee, bubbling water, and spiked drinks, offer a more discreet and convenient way of consumption. Cannabis candies and chocolates are also other discreet and controlled ways. The legal cannabis sector is always experimenting with new products, vaporizers, topicals, edibles, baked foods, and sprays. Cannabis is also used for pet treats quite frequently. It is believed to expand the market for edibles as much as consumer acceptability and legalization expand.

Reduce a full report cost up to 30% with a custom report by requesting here: https://www.prophecymarketinsights.com/market_insight/Insight/request-customization/5434

Recent Development:

  • In July 2024, Hundreds of pro-cannabis advocates took to Bangkok’s streets to protest a possible ban on general use. The Thai government floated plans to relist the plant as a narcotic, two years after it was decriminalized, earlier this year. A health ministry drug control committee approved the proposal, which would see cannabis only allowed for medical and research purposes.
  • In July 2024, NIST’s New Hemp Reference Material Will Help Ensure Accurate Cannabis Measurements. NIST’s Hemp Plant Reference Material will aid labs in accurately measuring THC, CBD, and other compounds in cannabis products, aiding forensic labs in distinguishing between legal hemp and federally controlled marijuana. It will also assist producers and state regulators in ensuring the safe use and accurate labeling of cannabis products.

Regional Insights

  • North America: The charge is currently being led from North America, due to early legalization and relatively permissive laws in countries like Canada and a number of US states. With so many goods on offer against the backdrop of a clientele base very loyal to their products, almost everything is put in place to create an almost perfect environment. The growth of the North American legal cannabis business is aided by many things, especially the medicinal and recreational markets, consumer demand, and lastly, medicinal research. The largest players are represented by Canopy Growth and Aurora Cannabis. The country with the most rapid growth relocated to Canada.
  • Asia Pacific: Asia is increasingly tolerating the use of medical marijuana, mainly in South Korea and Thailand, the growing disposable money of relatively less developed countries at large will set the stage for marijuana legalization for recreational use when regulations change.

Browse Detail Report on “Legal Cannabis Market Size, Share, By Source (Flowers, Seed oil, others), By Compound (Tetrahydrocannabinol, Cannabidiol, Balanced THC & CBD), By Product (Cannabis Oil, Cannabis Beverages, Cannabis Chocolates & Gummies, Others) By Application (Medical, Scientific, Industrial, and Horticultural purposes) and Region – Trends, Analysis and Forecast till 2034” with complete TOC @ https://www.prophecymarketinsights.com/market_insight/legal-cannabis-market-5434

Browse More Research Reports:

Frozen Food Market Size & Share Report, 2024-2034

Single Jersey Circular Knitting Machines Market Size & Share Report, 2024-2034

Concrete Admixtures Construction Chemical Market Size & Share Report, 2024-2034

Advertisement
Stake.com

Building Applied Photovoltaics Market Size & Share Report, 2024-2034

Cable Protection Market Size & Share Report, 2024-2034

About Us:

Prophecy Market Insights is a specialized market research, analytics, marketing, and business strategy, and solutions company that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. Also, we help our client to address business challenges and provide the best possible solutions to overcome them and transform their business.

Prophecy’s expertise area covers products, services, latest trends, developments, market growth factors, and challenges along with market forecasts in various business areas such as Healthcare, Pharmaceutical, Biotechnology, Information Technology (IT), Automotive, Industrial, Chemical, Agriculture, Food and Beverage, Energy, and Oil and Gas. We also offer various other services such as data mining, information management, and revenue enhancement suggestions.

Advertisement
Stake.com

Contact Us:

Prophecy Market Insights

US: 964 E. Badillo Street

#2042 Covina,

CA 91724

Advertisement
Stake.com

US toll-free: +1 860 531 2574

Rest of World: + 91 7775049802

Follow us on: LinkedIn | Twitter

Continue Reading

Cannabis

Global CBD Oil Market Size To Exceed USD 26.72 Billion By 2033 | CAGR of 18.36%

Published

on

New York, United States , July 09, 2024 (GLOBE NEWSWIRE) — The Global CBD Oil   Market Size Expected to Grow from USD 4.95 Billion in 2023 to USD 26.72 Billion by 2033, at a CAGR of 18.36% during the forecast period 2023-2033.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4887

Cannabidiol oil is another name for CBD oil. (CBD), which originates from cannabis plants, such as hemp and marijuana, can possess anxiolytic, anti-inflammatory, and analgesic properties. These characteristics have led to research on CBD oil as a possible treatment for a number of diseases, including anxiety disorders, chronic pain, and epilepsy. The demand for CBD-infused beauty and skincare products has surged, indicating consumers’ growing inclination towards natural and comprehensive skincare treatments. Growing amounts of CBD, which is well-known for its potential anti-inflammatory and antioxidant properties, are being added to skincare formulae to address issues including acne, inflammation, and aging. Governments from a number of states and countries are supporting its use in drugs and other medical treatments, which is expected to expand and increase these products’ sales and distribution throughout the course of the projected period. However, manufacturers continue to work to increase awareness among customers and provide informative packaging to make it clear what the consumer wants to get out of the items. Consequently, the attempts to support the marketing operations may present opportunities for the global cannabidiol oil market.  

Browse key industry insights spread across 232 pages with 110 Market data tables and figures & charts from the report on the “Global CBD Oil Market Size, Share, and COVID-19 Impact Analysis, By Source (Marijuana, Hemp), By Product (Full-Spectrum CBD Oil, Broad-Spectrum CBD Oil, CBD Isolate), By Application (Food & Beverages, Pharmaceuticals, Pet Care, Cosmetics, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033″

Buy Now Full Report: https://www.sphericalinsights.com/checkout/4887

Advertisement
Stake.com

The hemp segment is expected to hold the largest share of the CBD oil market during the anticipation timeframe.   

Based on the source, the CBD oil market is categorized into marijuana, and hemp. Among these, the hemp segment is expected to hold the largest share of the CBD oil market during the anticipation timeframe. Increased demand for pharmaceuticals and increased public awareness of health issues are likely to drive significant growth in the market for hemp-derived cannabidiol. The pharmaceutical industry predicts that when consumer disposable income increases and cannabis becomes legal, demand for the substance will rise.

The full-spectrum CBD oil segment is expected to grow at the fastest CAGR during the anticipation timeframe.    

Based on the product, the CBD oil market is categorized into full-spectrum CBD oil, broad-spectrum CBD oil, and CBD isolate. Among these, the full-spectrum CBD oil segment is expected to grow at the fastest CAGR during the anticipation timeframe. It indicates the combined benefits of many drugs may be more beneficial than CBD individually. With regard to the entourage effect, full-spectrum CBD oil is expected to have more medicinal benefits than CBD isolation. People may get improved relief from symptoms like pain, inflammation, anxiety, and more.

The pharmaceuticals segment is expected to hold a significant share of the CBD oil market   during the anticipation timeframe.

Advertisement
Stake.com

Based on the application, the CBD oil market is categorized into food & beverages, pharmaceuticals, pet care, cosmetics, and others. Among these, the pharmaceuticals segment is expected to hold a significant share of the CBD oil market during the anticipation timeframe. the growing number of research investigations evaluating CBD’s physical effects on particular medical conditions. These products are used as an alternative by a substantial, knowledgeable, and conscientious consumer base to lessen mental stress and nervousness.

Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/4887

North America is projected to hold the largest share of the CBD oil market over the anticipation timeframe.

North America is projected to hold the largest share of the CBD oil market over the anticipation timeframe. Interest from consumers in and tolerance to CBD have significantly increased in the US, which has significantly affected the market share and position of the area. North America is currently the largest market region because to ongoing development, pre-existing infrastructure, and growing public awareness of the potential benefits of CBD.

Europe is expected to grow at the fastest CAGR growth of the CBD oil market during the anticipation timeframe. The legalization of cannabis in a number of European countries has created new markets for CBD products, which will attract investment and encourage the creation of new goods. Moreover, the rise of CBD-infused goods in industries like wellness, food and drink, healthcare, and cosmetics encourages market progress in Europe and positions the region as a significant CBD oil market over the projection period.

Advertisement
Stake.com

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the CBD oil market are Aurora Cannabis Inc., BIOTA Biosciences LLC, CannazALL, Cannoid LLC, Canopy Growth Corp., CBD American Shaman LLC, CV Sciences Inc., Elixinol, Avicanna, Endoca BV, Folium Biosciences, Gaia Botanics, Green Roads Inc., Happie Hemp Pvt. Ltd., Kazmira LLC, Medical Marijuana Inc., and others.

Get Discount At @ https://www.sphericalinsights.com/request-discount/4887

Recent Developments

  • On January 2023, the acquisition of Goodbody Botanicals Ltd. by British Cannabis, a pioneer in the CBD market, represents a major advancement in our leadership in the wellness industry. This acquisition represents a significant expansion of our manufacturing capacity and an improvement in our ranking on the UK Food Standards Agency’s (FSA) list of authorized products, signifying more than just the joining of two firms.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the CBD oil market based on the below-mentioned segments: 

Advertisement
Stake.com

Global CBD Oil Market, By Source

  • Marijuana
  • Hemp

Global CBD Oil Market, By Product

  • Full-Spectrum CBD Oil
  • Broad-Spectrum CBD Oil
  • CBD Isolate

Global CBD Oil Market, By Application

  • Food & Beverages
  • Pharmaceuticals
  • Pet Care
  • Cosmetics
  • Others

Global CBD Oil Market, By Regional

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of the Middle East & Africa

Browse Related Reports

Global Resuscitation Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (External Defibrillators, Airway Management Devices, Convective Warming Blankets, and Other Resuscitation Devices), By Patient Type (Adult Patients, and Pediatric Patients), By End User (Hospitals, Ambulatory Surgical Centers (ASCs), Cardiac Centers, Pre-Hospital Care Settings and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033          

Global Tissue Diagnostics Market Size, Share, Growth Analysis, By Product (Consumables, and Instrument), By Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology & Workflow, and Special Staining), By Application (Breast Cancer, Prostate Cancer Gastric Cancer, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Global Smart Pills Market Size, Share, and COVID-19 Impact Analysis, By Target Area (Esophagus, Small Intestine, Large Intestine, and Stomach), By Application (Capsule Endoscopy, Drug Delivery, and Patient Monitoring), By End User (Hospital, Diagnostic Center, Research Institute, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Global LASIK Eye Surgery Market Size, Share, and COVID-19 Impact Analysis, By Type (Wavefront Optimized, Wavefront-Guided, Topography-Guided, and All Laser), By End-User (LASIK Eye Centers, Hospitals, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Advertisement
Stake.com

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Advertisement
Stake.com

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter

Advertisement
Stake.com

Continue Reading
Advertisement
Stake.com

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: sales@hipther.agency

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania